Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 83,115	$ 143,612
Accounts receivable, net of allowance for credit losses of $14,811 and $9,878, respectively	34,554	43,121
Inventories	80,353	62,600
Other current assets and prepaid expenses	12,961	19,852
Total current assets	210,983	269,185
Long-term inventories	13,825	16,283
Property and equipment, net	28,140	37,275
Deferred tax assets	508	579
Restricted cash	1,196	0
Goodwill	1,339	1,339
Operating lease right-of-use assets, net	11,388	10,055
Other long-term assets	8,916	11,575
Total assets	276,295	346,291
Current liabilities:
Accounts payable	17,617	19,829
Accrued liabilities	30,356	55,055
Operating lease liabilities	3,382	2,441
Deferred revenue	8,798	10,422
Total current liabilities	60,153	87,747
Deferred revenue, net of current portion	1,507	1,494
Operating lease liabilities, net of current portion	9,223	8,887
Convertible notes, net of unamortized debt issuance costs of $9,284 and $10,430, respectively	419,841	418,695
Other long-term liabilities	1,242	1,298
Total liabilities	491,966	518,121
Commitments and Contingencies (Note 12)
Stockholders’ deficit:
Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 20,108,406 and 19,960,622 shares at June 30, 2024 and December 31, 2023, respectively	20	20
Additional paid-in capital	135,114	131,496
Accumulated deficit	(350,805)	(303,346)
Total stockholders’ deficit	(215,671)	(171,830)
Total liabilities and stockholders’ deficit	$ 276,295	$ 346,291